Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells
暂无分享,去创建一个
L. Lopalco | A. Lazzarin | C. Pastori | M. Bomsel | D. Tudor | D. Ferrari | Chiara Alberti | C. Alberti | S. Garcia
[1] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[2] L. Lopalco,et al. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. , 2006, Blood.
[3] Robin Shattock,et al. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? , 2006, Nature Reviews Microbiology.
[4] L. Lopalco,et al. Is autoimmunity a component of natural immunity to HIV? , 2006, Current HIV research.
[5] A. Quayle,et al. Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone1 , 2005, Biology of reproduction.
[6] S. Zolla-Pazner,et al. A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs* , 2005, Journal of Biological Chemistry.
[7] M. Bomsel,et al. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. , 2005, Molecular biology of the cell.
[8] L. Lopalco,et al. Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy , 2005, Journal of Virology.
[9] L. Lopalco,et al. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. , 2005, The Journal of general virology.
[10] L. Lopalco,et al. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. , 2004, Blood.
[11] L. Lopalco. Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance? , 2004, Current HIV research.
[12] P. Wright,et al. Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. , 2003, Virology.
[13] S. Mason,et al. Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity. , 2003, The Journal of infectious diseases.
[14] J. Binley,et al. Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions , 2003, Journal of Virology.
[15] L. Lopalco,et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41 , 2002, AIDS.
[16] R. Bailey,et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. , 2002, The American journal of pathology.
[17] M. Bomsel,et al. HIV-1 gp41 Envelope Residues 650–685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide* , 2002, The Journal of Biological Chemistry.
[18] T. Hope,et al. Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization* , 2002, The Journal of Biological Chemistry.
[19] T. Strassmaier,et al. Grafting segments from the extracellular surface of CCR5 onto a bacteriorhodopsin transmembrane scaffold confers HIV-1 coreceptor activity. , 2002, Structure.
[20] M. Bomsel,et al. Mucosal gatekeepers: Selecting HIV viruses for early infection , 2002, Nature Medicine.
[21] J. Kappes,et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells , 2002, Nature Medicine.
[22] P. Ghys,et al. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. , 2001, The Journal of infectious diseases.
[23] A. Sette,et al. Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. , 2001, Human immunology.
[24] M. Kazatchkine,et al. Active and Selective Transcytosis of Cell-Free Human Immunodeficiency Virus through a Tight Polarized Monolayer of Human Endometrial Cells , 2001, Journal of Virology.
[25] M. Bomsel,et al. Secretory IgA Specific for a Conserved Epitope on gp41 Envelope Glycoprotein Inhibits Epithelial Transcytosis of HIV-11 , 2001, The Journal of Immunology.
[26] L. Lopalco,et al. Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells1 , 2000, The Journal of Immunology.
[27] J. Cummins,et al. Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. , 2000, Oral microbiology and immunology.
[28] L. Lopalco,et al. CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1 , 2000, The Journal of Immunology.
[29] M. Kagnoff,et al. Chemokine receptor expression by human intestinal epithelial cells. , 1999, Gastroenterology.
[30] M. McElrath,et al. Dendritic Cell–T-Cell Interactions Support Coreceptor-Independent Human Immunodeficiency Virus Type 1 Transmission in the Human Genital Tract , 1999, Journal of Virology.
[31] M. Bomsel,et al. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. , 1999, The Journal of infectious diseases.
[32] H. Guy,et al. Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.
[33] C. Dupont,et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. , 1998, Immunity.
[34] J. Phair,et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation , 1998, Nature Medicine.
[35] J J Goedert,et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) , 1998, Science.
[36] A. Blauvelt,et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection , 1997, Nature Medicine.
[37] M. Bomsel,et al. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. , 1997, AIDS research and human retroviruses.
[38] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[39] P. Bates. Chemokine Receptors and HIV-1: An Attractive Pair? , 1996, Cell.
[40] Q. Sattentau,et al. Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. , 1995, Virology.
[41] H. Moreau,et al. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells , 1992, Journal of virology.
[42] L. Lopalco,et al. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains , 1991, The Journal of experimental medicine.
[43] D. King,et al. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.
[44] J. Darlix,et al. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. , 2004, The international journal of biochemistry & cell biology.
[45] M. Bomsel. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier , 1997, Nature Medicine.